nse,bse,nseindia,nse india,share price,stock price,stock value,shares prices,share prices,stock quote,stock prices, share prices, corporate announcements,board meetings,corporate actions,dividends,agm,stock split,bonus

Neuland Laboratories Limited (NSE India Code : NEULANDLAB) BUY

Company Name :

Enter Company Name or NSE Code

NEULANDLAB Technical Levels

Resistance 2		148.88
Resistance 1		145.77
PIVOT		140.63
Support 1		137.52
Support 2		129.27

NEULANDLAB Fundamentals

Earning Growth		-99.99%
Profit Margin		1.48
PE		7.70
EPS		11.75
Quarter		30-Sep-11

NEULANDLAB Futures

Close
Contracts Traded
Open Interest(OI)
Change in OI
Lot Size

NEULANDLAB Options

Most Active Call
Most Active Put
Highest OI Call
Highest OI Put
Expiry Date

NEULANDLAB Technical Levels

Other Stocks from Pharmaceuticals Sector AARTIDRUGS ABBOTINDIA AJANTPHARM ALCHEM ALKALI ALPA AMRUTANJAN ANKURDRUGS ARL ASTRAZEN AUROPHARMA AVENTIS BALPHARMA BIOCON BLISSGVS CADILAHC CELESTIAL CIPLA DISHMAN DIVISLAB DRREDDY ELDERPHARM FDC FKONCO GLAXO GLENMARK GRANULES INDOCO INDSWFTLAB INDSWFTLTD IPCALAB JAGSNPHARM JBCHEPHARM JUBILANT KILITCH KOPRAN LUPIN LYKALABS MANGALAM MERCK MOREPENLAB NATCOPHARM NECLIFE NEULANDLAB OPTOCIRCUI ORCHIDCHEM PANACEABIO PARABDRUGS PFIZER PIRHEALTH

Sponsored Advertisement

NEULANDLAB Share Price on 5-10-2012

Open		143.5
High		144.95
Low		139.55
Close		142.3
Volume		3105
Change		-3.15 (-2.17%)

Series		EQ
Date of Listing		13-Oct-08
Paid Up Value		10
Face Value		10
Market Capital		0 Crores
52 Week High/Low		153 / 63.9

Sponsored Advertisement

Neuland Laboratories Limited Company Profile

Neuland Laboratories Ltd (NLL), established as a single product company, manufactures diversified range of Pharmaceutical products. The company was incorporated in 1984. It is a contract manufacturer for the drug and received FDA approval for manufacture of non-sterile APIs produced by chemical synthesis. It manufactures bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin. NLL has two manufacturing facilities close to the city of Hyderabad ( India ) which are located at Bonthapally and Pashamylaram. Both facilities are USFDA `systems` inspected and have the facilities of reactions including Bromination, Diazotization, Friedel - Craft, Hydrogenation, Mannich, Grignard, Metal Hydride reduction, Oxidation and Cryogenic reactions. Unit-1 with Six Blocks covering 2195 Sq. Mtrs is a small volume high value production facility and consists of reaction vessels that range between 20 litres through 300 litres. This facility with total Reactor Volume of 95 KL (M3) manufactures Anti-Asthmatics, Cardiovasculars, Anti-Bacterials, CNS and Anti-Fungal. Unit-2 with three blocks covering 1968 sq. Mt. is a high volume facility with dedicated production blocks for range of products including Fluoroquinlones, Anti-Ulcerants, and Prostaglandins. This facility has total reactor volume of 300 KL with a large reactor of 5000 litres size. The company also has well equipped research & development facilities at Bonthapally. NLL is recognized by the Govt. of India as an Export house. The Company has supplied its products to customers around the globe. Prominent markets include USA, Canada, Germany, France, United Kingdom, Italy, Korea, Japan, Taiwan, Australia, South Africa, Turkey, Jordan, Iran, Egypt, Brazil, Argentina, Mexico, and also East European countries. Neuland supplies APIs to over 75 countries.

NEULANDLAB Intraday Realtime Chart

NEULANDLAB Corporate Announcements

DATE	PURPOSE
01-Aug-12	Disclosure under SEBI Takeover Regulations
23-Jul-12	Address Change
18-Jul-12	Outcome of Postal Ballot
18-Jun-12	Notice of Postal Ballot
14-Jun-12	Updates

NEULANDLAB Corporate Actions

DATE	PURPOSE
03-Aug-12	Annual General Meeting
03-Aug-12	Annual General Meeting
21-Mar-12	Rights 5:12 @ Premium Rs.35/- Per Share
21-Mar-12	RHTS 5:12@PRM RS.35 PR SH
29-Jul-11	Annual General Meeting

NEULANDLAB Board Meetings

MEETING DATE	PURPOSE
10-Aug-12	Un-audited Financial Results
03-May-12	Audited Financial Results
19-Feb-12	Rights Issue
10-Feb-12	Un-audited Financial Results
03-Nov-11	Un-audited Financial Results

NEULANDLAB Related companies

Symbol	Company Name
AARTIDRUGS	Aarti Drugs Limited
ABBOTINDIA	Abbott India Limited
AJANTPHARM	Ajanta Pharma Limited
ALCHEM	Alchemist Limited
ALKALI	Alkali Metals Limited

Most Active NSE INDIA Stocks

HDFC LITL IVRCLINFRA HDIL UNITECH JPASSOCIAT GVKPIL TATAMOTORS IFCI IBREALEST ESSAROIL GMRINFRA BIRLAPOWER HINDALCO BHEL RENUKA RCOM DLF SUZLON RELCAPITAL IDFC ADANIENT ITC TATAPOWER BALLARPUR

Free Stock Market Tips:

What is an Abridged Prospectus?

Home	Stock Market	IPO	Mutual Funds	Education	Paid Service
About us	Share Market	IPO Watch	MF News	IPO	Subscription
VJonDalalStreet	Technical Analysis	New IPO Review	Old Funds	Articles	Equity Performance
DalalStreet Blog	Stock Market News	Indian IPO News	New Funds	Stock Market	Futures Performance
Free Sms Alerts	World Stock Market	IPO Allotment Status	Best Funds	Financial Terms	Options Performance
Privacy	Stock Recommendations	Grey Market Premium	MF Analysis	Futures & Options	Jackpot Performance

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither VJonDalalStreet.com website nor any of its promoters shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes acceptance of our Disclaimer